Georgia ranks among worst states for lung cancer early diagnosis at 40th, according to new report

American Lung Association examines toll of lung cancer in Georgia, underscores urgent need for more people to be screened

Georgia ranks among worst states for lung cancer early diagnosis at 40th, according to new report

The 2022 “State of Lung Cancer” report reveals that Georgia ranks 40th in the nation for early lung cancer diagnosis. The American Lung Association’s 5th annual report, released today, highlights the toll of lung cancer in Georgia and examines key indicators including new cases, survival, early diagnosis, surgical treatment, lack of treatment and screening rates.

Nationally, the “State of Lung Cancer” report shows continued progress for lung cancer survival. The lung cancer five-year survival rate is now 25% and increased 21% from 2014 to 2018. Here in Georgia, the lung cancer survival rate is below the national average at 22.5%. The report also highlights that people of color who are diagnosed with lung cancer face worse outcomes compared to white Americans, including lower survival rate, less likely to be diagnosed early, less likely to receive surgical treatment and more likely to receive no treatment. In Georgia, Asian Americans or Pacific Islanders are least likely to be diagnosed early.

“Lung cancer screening is key to early diagnosis, and early diagnosis saves lives. Unfortunately, here in Georgia not enough people are getting this lifesaving screening,” said Ashley Lyerly, senior director of advocacy for Georgia at the American Lung Association. “We all can help reduce the burden of lung cancer in Georgia. If you are eligible for lung cancer screening, we encourage you to speak with your doctor about it. If a loved one is eligible, please encourage them to get screened.”

Currently, 14.2 million Americans meet the US Preventive Services Task Force guidelines for screening. Under these guidelines, a person is eligible for lung cancer screening if they if are between 50-80 years of age, have a 20 pack-year history (1 pack/day for 20 years, 2 packs/day for 10 years) and are a current smoker, or have quit within the last 15 years. Find out if you are eligible for lung cancer screening at SavedByTheScan.org.

The report found that Georgia ranked:

29th in the nation for rate of new lung cancer cases at 60.2 per 100,000. The national rate is 56.7 per 100,000.

36th in the nation for survival at 22.5%. The national rate of people alive five years after a lung cancer diagnosis is 25%.

40th in the nation for early diagnosis at 24%. Nationally, only 25.8% of cases are diagnosed at an early stage when the survival rate is much higher.

35th in the nation for lung cancer screening at 5%. Lung cancer screening with annual low-dose CT scans for those at high risk can reduce the lung cancer death rate by up to 20%. Nationally, only 5.8% of those at high risk were screened.

32rd in the nation for surgery at 18.5%. Lung cancer can often be treated with surgery if it is diagnosed at an early stage and has not spread. Nationally, 20.8% of cases underwent surgery.

37th in the nation for lack of treatment at 22.3%. Nationally, 20.6% of cases receive no treatment.

Another noteworthy rating identified for Georgia is the radon action level. 21.5% of homes in Georgia are above the recommended action level by the EPA for radon. And while this is average, more work should be done. The only way to know one’s radon level is to test, so the Lung Association recommends all homes, schools, and workplaces should be tested, and high levels, if confirmed, should be reduced. Most will get good news, but every now and then, high values will be found and should be fixed.

“State of Lung Cancer” highlights that Georgia must do more to reduce the burden of lung cancer and encourages everyone to join the effort to end lung cancer. Learn more about the report, and email President Biden to thank him for his leadership on the Cancer Moonshot Initiative and urge him to work to increase lung cancer screening for individuals at high risk at Lung.org/solc.

Facebook
Twitter
LinkedIn
Pinterest
Email